Sign In
Free Newsletter
Pennsylvania getting second $1B+ biopharma investment
Johnson & Johnson will invest $1 billion to build a cell therapy manufacturing facility in Montgomery County, creating 500 jobs in Pennsylvania.
High Properties acquires Johnson & Johnson plant for $14M
High Properties LLC bought the 144,000-square-foot Johnson & Johnson Consumer Health plant in East Lampeter Township for $14 million, according to a deed filed last month at the Lancaster County Courthouse.
Pa. resumes use of Johnson & Johnson’s COVID-19 vaccine
Pennsylvania has resumed use of Johnson & Johnson’s COVID-19 vaccine, following a thorough federal review which reaffirmed the vaccine’s safety and effectiveness against the virus, according to the Harrisburg-based Hospital and Health System Association of Pennsylvania.
Johnson & Johnson vows to add 50% more Black managers in five years
Johnson & Johnson plans to increase the number of Black managers in the company by 50% within five years as part of a $100 million initiative to tackle racial inequality, executives said Tuesday.
Miller chosen to lead Saxton & Stump’s cybersecurity practice
A compliance and cybersecurity consultant specialist and attorney has joined Saxton & Stump as a member of its senior counsel and will take charge of its cybersecurity practice.
The Whiteboard: The opioid crisis threatens to bring down some unexpected consumer brands
Two weeks ago, an Oklahoma court awarded a judgment of more than $570 million dollars against Johnson & Johnson for their role in the opioid crisis. Ironically, their stock price actually went up because the market was expecting a larger award.
